NIH Approves Clinical Trials as Mitragynine Gets “Investigational New Drug” Status
On June 1, the National Institutes of Health (NIH) announced that mitragynine, the most abundant alkaloid in kratom, has been cleared as an Investigational New Drug (IND). With IND status, scientists at University of Florida are now authorized to study the effects of pure mitragynine in human subjects. National Institute on Drug Abuse (NIDA) Director …
NIH Approves Clinical Trials as Mitragynine Gets “Investigational New Drug” Status Read More »